Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Is QUALIOST appropriate for the patients with orthotopic liver transplantation in measuring quality of life?

Atamaz F, Hepguler S, Ozturk C, Pinar Y.

Transplant Proc. 2013 Jan-Feb;45(1):286-9. doi: 10.1016/j.transproceed.2012.10.027.

PMID:
23375317
2.

Cross-cultural validation and analysis of responsiveness of the QUALIOST: QUAlity of Life questionnaire In OSTeoporosis.

de la Loge C, Sullivan K, Pinkney R, Marquis P, Roux C, Meunier PJ.

Health Qual Life Outcomes. 2005 Nov 10;3:69.

3.

Acceptability, validity and reliability of the Turkish QUALIOST(®) in postmenopausal women with osteoporosis.

Hepguler S, Atamaz FC, Pinar Y, Ozturk C.

Rheumatol Int. 2013 Mar;33(3):757-61. doi: 10.1007/s00296-012-2443-z. Epub 2012 May 15.

PMID:
22585357
4.

Validity and reliability of the Italian version of the ECOS-16 questionnaire in postmenopausal women with prevalent vertebral fractures due to osteoporosis.

Salaffi F, Malavolta N, Cimmino MA, Di Matteo L, Scendoni P, Carotti M, Stancati A, Mulé R, Frigato M, Gutierrez M, Grassi W; Italian Multicentre Osteoporotic Fracture (IMOF) Study Group.

Clin Exp Rheumatol. 2007 May-Jun;25(3):390-403.

PMID:
17631735
5.

Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis.

Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O, Kanis JA, Kellingray S, Leplege A, Liberman UA, McCloskey E, Minne H, Reeve J, Reginster JY, Scholz M, Todd C, de Vernejoul MC, Wiklund I.

Osteoporos Int. 1999;10(2):150-60.

PMID:
10501796
6.

Validation of the osteoporosis quality of life questionnaire QUALEFFO-41 for the Serbian population.

Tadic I, Vujasinovic Stupar N, Tasic L, Stevanovic D, Dimic A, Stamenkovic B, Stojanovic S, Milenkovic S.

Health Qual Life Outcomes. 2012 Jun 18;10:74. doi: 10.1186/1477-7525-10-74.

7.

Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation.

Alcalde Vargas A, Pascasio Acevedo JM, Gutiérrez Domingo I, García Jiménez R, Sousa Martín JM, Ferrer Ríos MT, Sayago Mota M, Giráldez Gallego A, Gómez Bravo MA.

Transplant Proc. 2012 Jul-Aug;44(6):1496-8. doi: 10.1016/j.transproceed.2012.05.011.

PMID:
22841194
8.
9.

Comparing morphometric X-ray absorptiometry and radiography in defining vertebral wedge fractures in patients with ankylosing spondylitis.

Vosse D, Heijckmann C, Landewé R, van der Heijde D, van der Linden S, Geusens P.

Rheumatology (Oxford). 2007 Nov;46(11):1667-71. Epub 2007 Sep 5.

10.

Incidence of vertebral fractures in the first three months after orthotopic liver transplantation.

Ninkovic M, Skingle SJ, Bearcroft PW, Bishop N, Alexander GJ, Compston JE.

Eur J Gastroenterol Hepatol. 2000 Aug;12(8):931-5.

PMID:
10958221
11.

Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.

Monegal A, Navasa M, Guañabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodés J, Muñoz-Gómez J.

Calcif Tissue Int. 1997 Feb;60(2):148-54.

PMID:
9056162
12.

Reliability and validity of the Turkish version of the mini Osteoporosis Quality of Life Questionnaire.

Yilmaz F, Sahin F, Dogu B, Ozmaden A, Kuran B.

J Back Musculoskelet Rehabil. 2012;25(2):89-94. doi: 10.3233/BMR-2012-0314.

PMID:
22684199
13.

The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study.

Salaffi F, Cimmino MA, Malavolta N, Carotti M, Di Matteo L, Scendoni P, Grassi W; Italian Multicentre Osteoporotic Fracture Study Group.

J Rheumatol. 2007 Jul;34(7):1551-60. Epub 2007 May 15.

PMID:
17516618
14.

Health-related quality of life in patients with osteopenia or osteoporosis with and without fractures in a geriatric rehabilitation department.

Jahelka B, Dorner T, Terkula R, Quittan M, Bröll H, Erlacher L.

Wien Med Wochenschr. 2009 May;159(9-10):235-40. doi: 10.1007/s10354-009-0655-y.

PMID:
19484206
15.

Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation.

Atamaz F, Hepguler S, Akyildiz M, Karasu Z, Kilic M.

Osteoporos Int. 2006;17(6):942-9. Epub 2006 Mar 21.

PMID:
16550299
16.

Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.

Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L.

Am J Med. 1996 Sep;101(3):262-9.

PMID:
8873487
17.

Bone loss after orthotopic liver transplantation.

Meys E, Fontanges E, Fourcade N, Thomasson A, Pouyet M, Delmas PD.

Am J Med. 1994 Nov;97(5):445-50.

PMID:
7977433
18.

The reliability and validity of the Turkish version of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO).

Koçyigit H, Gülseren S, Erol A, Hizli N, Memis A.

Clin Rheumatol. 2003 Feb;22(1):18-23.

PMID:
12605312
19.

Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation.

Reeves HL, Francis RM, Manas DM, Hudson M, Day CP.

Liver Transpl Surg. 1998 Sep;4(5):404-9.

20.

Impact of degenerative radiographic abnormalities and vertebral fractures on spinal bone density of women with osteoporosis.

Paiva LC, Filardi S, Pinto-Neto AM, Samara A, Marques Neto JF.

Sao Paulo Med J. 2002 Jan 3;120(1):9-12.

Items per page

Supplemental Content

Write to the Help Desk